Found 161 matching trials
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery PHASE2 This is a single-arm, single-center feasibility trial of patients with bord...
Show More Location
Juravinski Hospital
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer NA This is a multi-center clinical study enrolling up to 50 participants. The ...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer PHASE3 The PREOPANC-3 study is a randomized, multicenter, phase 3 trial. Patients ...
Show More Status
Active Not Recruiting
Location
Jeroen Bosch Hospital
Learn More & Join Trial
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer PHASE2 Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Show More Location
Baylor College of Medicine
Learn More & Join Trial
A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for Patients With Resectable Borderline Pancreatic Adenocarcinoma (PDAC) NA Pancreatic cancer exhibits significant heterogeneity, which poses a major c...
Show More Location
Multiple Locations
Learn More & Join Trial
BBO-11818 in Adult Subjects With KRAS Mutant Cancer PHASE1 A first in human study to evaluate the safety and preliminary antitumor act...
Show More Location
The Angeles Clinic and Research Institute - West Los Angeles Office
Learn More & Join Trial
Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma PHASE2 Surgical resection is the only potentially curative treatment for patients ...
Show More Location
Smilow Cancer Hospital
Learn More & Join Trial
Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma PHASE1 The prognosis of pancreatic cancer is extremely poor. Current guidelines re...
Show More Location
The second affiliated hospital of Zhejiang University
Learn More & Join Trial
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. N/A Ampullary adenocarcinoma (AAC) is a rare gastrointestinal cancer with varyi...
Show More Location
Fondazione Poliambulanza
Learn More & Join Trial